Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
PTGX Price/Volume Stats
| Current price | $38.00 | 52-week high | $48.89 |
| Prev. close | $39.57 | 52-week low | $21.71 |
| Day low | $37.48 | Volume | 372,781 |
| Day high | $39.85 | Avg. volume | 396,938 |
| 50-day MA | $42.68 | Dividend yield | N/A |
| 200-day MA | $37.54 | Market Cap | 2.26B |
PTGX Stock Price Chart Interactive Chart >
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
PTGX Price Returns
| 1-mo | -9.65% |
| 3-mo | -13.56% |
| 6-mo | 9.26% |
| 1-year | 74.39% |
| 3-year | 9.01% |
| 5-year | 447.95% |
| YTD | -1.55% |
| 2024 | 68.34% |
| 2023 | 110.17% |
| 2022 | -68.10% |
| 2021 | 69.64% |
| 2020 | 185.96% |
Loading social stream, please wait...